SIEN Key Statistics, Chart & Performance
The current stock price of SIEN is 0.174 USD. In the past month the price decreased by -69.47%. In the past year, price decreased by -89.45%.
SIEN Technical Analysis
SIEN Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to SIEN. Both the profitability and financial health of SIEN have multiple concerns.
SIEN Financial Highlights
Over the last trailing twelve months SIEN reported a non-GAAP Earnings per Share(EPS) of -5.57. The EPS increased by 48.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -42.26% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
SIEN Forecast & Estimates
9 analysts have analysed SIEN and the average price target is 2.04 USD. This implies a price increase of 1072.41% is expected in the next year compared to the current price of 0.174.
For the next year, analysts expect an EPS growth of 61.42% and a revenue growth -3.12% for SIEN
SIEN Ownership
SIEN Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 18.2 | 16.217B | ||
| ALGN | ALIGN TECHNOLOGY INC | 17.63 | 14.082B | ||
| SOLV | SOLVENTUM CORP | 12.59 | 13.956B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 19.7 | 4.875B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.9 | 4.454B | ||
| ICUI | ICU MEDICAL INC | 18.01 | 3.783B | ||
| XRAY | DENTSPLY SIRONA INC | 8.81 | 2.78B | ||
| HAE | HAEMONETICS CORP/MASS | 10.47 | 2.763B | ||
| NEOG | NEOGEN CORP | 31.7 | 2.332B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.28 | 2.063B |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SIEN
Company Profile
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Irvine, California and currently employs 304 full-time employees. The company went IPO on 2014-10-29. The firm is engaged in transformative treatments and technologies focused on advancing plastic surgery. The firm provides medical aesthetics products to certified plastic surgeons and patients. The company has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The firm sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
Company Info
SIENTRA INC
3333 Michaelson Dr, Suite 650
Irvine CALIFORNIA 93117 US
CEO: Ronald Menezes
Employees: 304
Phone: 18055623500
SIENTRA INC / SIEN FAQ
Can you describe the business of SIENTRA INC?
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Irvine, California and currently employs 304 full-time employees. The company went IPO on 2014-10-29. The firm is engaged in transformative treatments and technologies focused on advancing plastic surgery. The firm provides medical aesthetics products to certified plastic surgeons and patients. The company has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The firm sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
What is the current price of SIEN stock?
The current stock price of SIEN is 0.174 USD. The price decreased by -18.69% in the last trading session.
What is the dividend status of SIENTRA INC?
SIEN does not pay a dividend.
What is the ChartMill rating of SIENTRA INC stock?
SIEN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the expected growth for SIEN stock?
The Revenue of SIENTRA INC (SIEN) is expected to decline by -3.12% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for SIENTRA INC?
SIENTRA INC (SIEN) has a market capitalization of 2.08M USD. This makes SIEN a Nano Cap stock.
Who owns SIENTRA INC?
You can find the ownership structure of SIENTRA INC (SIEN) on the Ownership tab.